CORRECTION: MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten
BRISBANE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline on Monday, August 3rd […]
BRISBANE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline on Monday, August 3rd […]
ARLINGTON, Va., Aug. 03, 2020 (GLOBE NEWSWIRE) — A majority of North American employers expect that most of their furloughed […]
AUSTIN, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) — On July 31, 2020, Ideal Power Inc. (Nasdaq: IPWR) (the “Company” or […]
HONG KONG, Aug. 03, 2020 (GLOBE NEWSWIRE) — Sky Solar Holdings, Ltd. (NASDAQ: SKYS) (“Sky Solar” or the “Company”), a […]
SEATTLE, Aug. 03, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop […]
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Aspen Group, Inc. (“AGI”) (Nasdaq: ASPU), an education technology holding company, announced […]
– IW-6463 and olinciguat top line clinical study results remain on track for late summer and late Q3 2020, respectively –– […]
BASKING RIDGE, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Continuing its global 5G leadership, Verizon has become the first US […]
RESEARCH TRIANGLE PARK, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused […]
BEVERLY HILLS, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — After four years of development and production, Genius Brands International, Inc. […]